非肝硬化性门静脉高压自然史研究
该数据集来自 clinicaltrials.gov,聚焦非肝硬化性门静脉高压(NCPH)的自然史研究。覆盖囊性纤维化、免疫缺陷综合征、Turner 综合征、先天性肝纤维化及特发性非肝硬化性门静脉高压等基础疾病人群,计划纳入最多 400 名受试者

基本信息
资源简介
非肝硬化性门静脉高压自然史研究
该数据集来自 clinicaltrials.gov,聚焦非肝硬化性门静脉高压(NCPH)的自然史研究。覆盖囊性纤维化、免疫缺陷综合征、Turner 综合征、先天性肝纤维化及特发性非肝硬化性门静脉高压等基础疾病人群,计划纳入最多 400 名受试者。数据可用于探索 NCPH 的发生与进展规律,发现新型生物标志物,以改善患者随访、预防并发症并辅助移植决策,同时支持胆汁酸与脂质测量及门体分流相关研究(来源 clinicaltrials.gov)。
【数据内容】
源站描述(机器翻译,仅供参考):疾病:囊性纤维化、免疫缺陷综合征、Turner 综合征、先天性肝纤维化、特发性非肝硬化性门静脉高压。研究描述:最多 400 名患有非肝硬化性门静脉高压或因其基础疾病而有发生非肝硬化性门静脉高压风险的受试者(以及本方案中提及的散发性非肝硬化性门静脉高压病例)将被纳入本研究。目标:主要目标:1. 本自然史研究的目标是增进对 NCPH 发生与进展的理解。我们将利用研究结果生成新型生物标志物,以改善患者随访、帮助预防并发症并增强移植决策。次要目标:1. 测量胆汁酸和脂质以理解 NCPH 与门体分流。2. Id
【主题与分类】
主题标签:Cystic Fibrosis、Immunologic Deficiency Syndrome、Turner Syndrome、Congenital Hepatic Fibrosis。本站分类:循环系统疾病/其他。
【获取与许可】
源站页面:https://clinicaltrials.gov/study/NCT02417740
下载信息
注册下载
需要注册 Kaggle 账号并登录后下载,适合需要跟踪下载记录和使用 API 的用户。
暂未开放公开下载
无需注册即可直接获取公开样本或文档,适合快速预览和评估数据集质量。
免登录有偿下载
公开数据集受托下载与技术交付服务。
提供高速下载与技术交付服务(收技术服务费,非数据销售)
暂未开放当前数据集主要来源为 Kaggle 公开托管,完整影像包建议通过原始链接或 Kaggle API 获取。
使用方式
数据集获取
源站:https://clinicaltrials.gov/study/NCT02417740
标准获取流程:
- 访问源站链接,注册/登录账号;
- 进入数据集详情页,按页面指引申请权限或直接下载;
- 部分平台提供 SDK,例如:
- OpenDataLab:
pip install openxlab后openxlab.dataset.get(...) - ModelScope:
pip install modelscope后modelscope download - 天池: 登录后页面提供直链下载
以源站「数据下载/使用文档」页面为准。
- OpenDataLab:
数据说明
Conditions: Cystic Fibrosis, Immunologic Deficiency Syndrome, Turner Syndrome, Congenital Hepatic Fibrosis, Idiopathic Non-Cirrhotic Portal Hypertension. Study Description: Up to 400 subjects with noncirrhotic portal hypertension or at risk for developing noncirrhotic portal hypertension by virtue of their underlying disease (as well as sporadic cases of noncirrhotic portal hypertension as referred to in this protocol) will be offered inclusion in the study. Objectives: Primary Objective: 1. The goal of this natural history study is to generate understanding of the development and progression of NCPH. We will use our findings to generate novel biomarkers that will enable improved follow-up of patients, assist in preventing complications, and enhance transplant decision. Secondary Objectives: 1. Measurement of the bile acids and lipids to understand NCPH and porto-systemic shunting. 2. Identification of the genetic modifiers of NCPH. 3. Evaluation of hepatic transcriptome in absence and presence of NCPH. 4. Characterization of microbiome signatures in NCPH. Endpoints: Primary Endpoints: 1. Establish surveillance methods and guidelines for evaluation of NCPH. 2. Develop an understanding of the biological mechanisms of the progression of NCPH. 3. Identification of novel biomarkers correlating with NCPH progression. Secondary Endpoints: 1. Measurement of bile acids fractionated and total, as well as lipid panel to establish cut-off levels correlating with NCPH severity. 2. Establishment of positive or negative correlation between candidate susceptible genes and disease phenotype. 3. Identification of novel markers of fibrosis or the development of hepatic neoplasia from transcriptome analysis. 4. Characterization of microbiome signatures (taxonomic and functional), as well as identification of specific species.
数据加载示例(图像类)
from PIL import Image
import glob, os
files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
+ glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)
# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path) # 要求 子目录=类别
目录组织与标注格式以源站说明和下载后实际文件为准。
数据缺失?
依托陕西、四川两大基地,我们与超过十家三甲医院建立直接合作关系,覆盖合规授权、采集治理、专业标注、数据交付的全流程,为AI医疗团队提供即拿即用的高质量临床数据。
⚡️ 需要数据支持或标注服务?立即联系我们获取专业方案。




